|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.1 mM||21.7 mL||108.51 mL||217.01 mL|
|0.5 mM||4.34 mL||21.7 mL||43.4 mL|
|1 mM||2.17 mL||10.85 mL||21.7 mL|
|5 mM||0.43 mL||2.17 mL||4.34 mL|
*The above data is based on the productmolecular weight 460.8 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|MECHANISM OF ACTION||Inhibitor|
|Storage||at -20°C 3 years Powder|
ARRY334543 is a potent, orally active small molecule inhibitor of EGFR and ErbB-2.
PD153035 is an extremely potent and specific inhibitor of the tyrosine kinase activity of EGFR.
Gefitinib is an EGFR inhibitor, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells.
Pelitinib (EKB-569) is a 3-cyanoquinoline pan-ErbB tyrosine kinase inhibitor with potential antineoplastic activity.
Lapatinib is a dual tyrosine kinase inhibitor which interrupts the HER2 growth receptor pathway.
Mubritinib (TAK 165) is a potent EGFR and p34cdc2 inhibitor with IC50 of 6 nM and 0.2 µM, respectively. Mubritinib(TAK 165) also inhibits p…
OSI-420 (Desmethyl Erlotinib,CP-473420) is an orally active EGFR tyrosin kinase inhibitor, which inhibits receptor tyrosine kinases (TKs) by…